Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4Sarcoma 1

Conditions

Sarcoma 9Osteosarcoma 4Sarcoma, Ewing 3Rhabdomyosarcoma 3Neuroblastoma 3Neoplasms 3Medulloblastoma 3Glioma 3Ependymoma 3Central Nervous System Neoplasms 3Carcinosarcoma 3Wilms Tumor 2Rhabdoid Tumor 2Recurrence 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Glioblastoma 2Endometrial Neoplasms 2Carcinoma, Endometrioid 2Breast Neoplasms 2Xanthogranuloma, Juvenile 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Sarcoma, Synovial 1Prostatic Neoplasms 1Pheochromocytoma 1Pathologic Complete Response 1

Interventions

pembrolizumab 4Specimen Handling 3Magnetic Resonance Spectroscopy 3tislelizumab 2aflibercept 2Surveys and Questionnaires 2Radiotherapy 2Gene Expression Profiling 2Fentanyl 2Docetaxel 2Diet Therapy 2Blood Specimen Collection 2Biopsy 2trastuzumab deruxtecan 1toripalimab 1spartalizumab 1sargramostim 1rucaparib 1pegfilgrastim 1pazopanib 1olaparib 1milademetan 1entinostat 1durvalumab 1ciforadenant 1ceralasertib 1cemiplimab 1avelumab 1X-Rays 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × olaparib × Sarcoma × Clear all
NCT04065269 2026-02-20

ATARI

Institute of Cancer Research, United Kingdom

Phase 2 Active not recruiting
174 enrolled
GynecologicSarcoma

Carcinosarcoma, Uterine Cervical Neoplasms, Endometrial Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡